{"id":"cc00e9eb-a607-5713-8ba8-fdef3c75d620","stable_key":"cab605fe-8a82-5191-9966-d19a9628c24c:betalains-indicaxanthin-transport","predicate":"has_low_apparent_permeability","statement":"Indicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"9c2db383-45cc-5b1f-8c8a-9733877e74c9","mechanism_event_label":"Indicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.","subject":{"id":"f2a6e469-05f0-5596-9054-da926389f584","slug":"indicaxanthin","display_name":"Indicaxanthin","entity_type_key":"small_molecule"},"object":{"id":"c92e133a-dd5c-5e93-8b89-ef96c3539e56","slug":"human-caco2-indicaxanthin-permeability","display_name":"Apparent indicaxanthin permeability in human Caco-2 monolayers","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"9c2db383-45cc-5b1f-8c8a-9733877e74c9","stable_key":"cab605fe-8a82-5191-9966-d19a9628c24c:betalains-indicaxanthin-transport-event","event_type":"observed_relationship","label":"Indicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.","description":"Indicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"f2a6e469-05f0-5596-9054-da926389f584","slug":"indicaxanthin","display_name":"Indicaxanthin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"c92e133a-dd5c-5e93-8b89-ef96c3539e56","slug":"human-caco2-indicaxanthin-permeability","display_name":"Apparent indicaxanthin permeability in human Caco-2 monolayers","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"dose","value_text":"Betalains 5-80 micromolar","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Not specified in accessed primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_scope","value_text":"literature_reviewed; source-derived curation, not universally established human effects","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human Caco-2 intestinal epithelial cell model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Low apparent permeability in cultured cells is not a measured human oral bioavailability fraction; findings depend on pigment and assay. The range spans the three compounds; it is not an assigned compound-specific coefficient.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Betalains collection; each molecular form, species, exposure and preparation remains explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"betalains","display_name":"Betalains","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human Caco-2 intestinal epithelial cell model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Indicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Uptake and Immunomodulatory Properties of Betanin, Vulgaxanthin I and Indicaxanthin towards Caco-2 Intestinal Cells. (2022). https://pubmed.ncbi.nlm.nih.gov/36009345/ DOI: 10.3390/antiox11081627","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro exposure","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Intestinal cells and monolayer transport","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"7fdd11f6-8694-58aa-83ae-66db13fa05a6","evidence_kind":"source_excerpt","locator":"Lines 377-385","start_line":377,"end_line":385,"excerpt":"## betalains-indicaxanthin-transport\nIndicaxanthin showed low apparent permeability across Caco-2 monolayers; the reported three-pigment range was 4.2-8.9 x 10^-7 cm/s.\nModel/species: Human Caco-2 intestinal epithelial cell model\nTissue: Intestinal cells and monolayer transport\nExposure: Betalains 5-80 micromolar\nRoute: In vitro exposure\nDuration: Not specified in accessed primary abstract\nLimits: Low apparent permeability in cultured cells is not a measured human oral bioavailability fraction; findings depend on pigment and assay. The range spans the three compounds; it is not an assigned compound-specific coefficient.\nPrimary reference: Uptake and Immunomodulatory Properties of Betanin, Vulgaxanthin I and Indicaxanthin towards Caco-2 Intestinal Cells. (2022). https://pubmed.ncbi.nlm.nih.gov/36009345/ DOI: 10.3390/antiox11081627","model_system":"Human Caco-2 intestinal epithelial cell model","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Exact archived curation span; an original paraphrase with an individually identified primary reference.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"be94d093-444c-5729-8831-bc33b0ef2fd7","stable_key":"import-cab605fe-8a82-5191-9966-d19a9628c24c","title":"Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20)","document_type":"imported_text","citation_label":"Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text.","file_path":"","sha256":"adb4fb8586481a69da5d2fe5cf62ad1dae2509af524352673fc7427123eeda87","revision_id":"a328b3f9-66d2-59e2-bd8f-de651c3c7649","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}